FLEXACCESS Trademark

Trademark Overview

On Thursday, January 13, 2022, a trademark application was filed for FLEXACCESS with the United States Patent and Trademark Office. The USPTO has given the FLEXACCESS trademark a serial number of 97217862. The federal status of this trademark filing is REGISTERED as of Tuesday, September 26, 2023. This trademark is owned by Prime Therapeutics LLC. The FLEXACCESS trademark is filed in the Advertising, Business and Retail Services and Insurance & Financial Services categories with the following description:

Pharmacy benefit management services

Pharmaceutical cost management services; medical cost management in the field of pharmaceuticals; providing information in the field of prescription drug savings programs for consumers; administration of a program for enabling participants to obtain discounts on prescription drug spending through a copay discount program; administration of a discount program for enabling participants to obtain discounts on prescription drugs through the use of coupons
flexaccess

General Information

Serial Number97217862
Word MarkFLEXACCESS
Filing DateThursday, January 13, 2022
Status700 - REGISTERED
Status DateTuesday, September 26, 2023
Registration Number7177513
Registration DateTuesday, September 26, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 29, 2022

Trademark Statements

Pseudo MarkFLEX ACCESS
Goods and ServicesPharmacy benefit management services
Goods and ServicesPharmaceutical cost management services; medical cost management in the field of pharmaceuticals; providing information in the field of prescription drug savings programs for consumers; administration of a program for enabling participants to obtain discounts on prescription drug spending through a copay discount program; administration of a discount program for enabling participants to obtain discounts on prescription drugs through the use of coupons

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, October 26, 2022
Primary Code035
First Use Anywhere DateSunday, January 1, 2023
First Use In Commerce DateSunday, January 1, 2023
International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, January 20, 2022
Primary Code036
First Use Anywhere DateSunday, January 1, 2023
First Use In Commerce DateSunday, January 1, 2023

Trademark Owner History

Party NamePrime Therapeutics LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressEagan, MN 55121
Party NamePrime Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressEagan, MN 55121
Party NamePrime Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEagan, MN 55121

Trademark Events

Event DateEvent Description
Wednesday, October 26, 2022EXAMINERS AMENDMENT E-MAILED
Monday, January 17, 2022NEW APPLICATION ENTERED
Thursday, January 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 20, 2022ASSIGNED TO EXAMINER
Wednesday, October 26, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 26, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 26, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, October 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 29, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 24, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 24, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 24, 2023SOU EXTENSION 1 FILED
Monday, July 24, 2023SOU EXTENSION 1 GRANTED
Wednesday, July 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 27, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, July 27, 2023USE AMENDMENT FILED
Wednesday, August 9, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 9, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, August 21, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 22, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 26, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, September 26, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, December 21, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 21, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 21, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 21, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 12, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 12, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 21, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

flexaccess prescription management program participants through discounts enabling drug discount services